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Abstract 
 
Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for 
the treatment of cancer. Despite the importance of MSAs for medical applications and basic 
research, their molecular mechanisms of action on tubulin and microtubules remain elusive. 
Here we determined high-resolution crystal structures of -tubulin in complex with two 
unrelated MSAs, zampanolide and epothilone A. Both compounds were bound to the taxane-
pocket of -tubulin and used their respective side chain to induce structuring of the M-loop into a 
short helix. Because the M-loop establishes lateral tubulin contacts in microtubules, these 
findings explain how taxane-site MSAs promote microtubule assembly and stability. They further 
offer fundamental structural insights into the control mechanisms of microtubule dynamics.  
 
 
 
One sentence summary:  
Microtubule-stabilizing agents use a common mechanism to stabilize a major loop in tubulin that 
controls microtubule assembly and stability.  
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The binding of MSAs like Taxol to microtubules is generally thought to shift the assembly 
equilibrium of tubulin towards the polymeric state and to block cell entry into mitosis by 
suppressing microtubule dynamics (1, 2). However, MSAs are also known to induce microtubule 
polymerization under conditions where tubulin does not assemble spontaneously, suggesting a 
role in tubulin activation (3, 4). To provide insights into the interactions of MSAs with tubulin and 
microtubules at the molecular level, we crystallized the complex between -tubulin, the 
stathmin-like protein RB3 and tubulin tyrosine ligase (TTL) in the presence of either 
zampanolide (Zampa) or epothilone A (EpoA) (Fig. 1A), and determined the structures of the 
corresponding protein-ligand complexes (T2R-TTL-Zampa and (T2R-TTL-EpoA) by X-ray 
crystallography (Fig. S1A; Table S1) (5). The two tubulin heterodimers in the T2R-TTL-MSA 
complexes were aligned in a head-to-tail fashion and assumed a curved conformation. Their 
overall structures superimposed well with the ones obtained in the absence of a MSA or of 
tubulin in complex with RB3 alone (6) (rmsd ranging from 0.1-0.6 Å over >650 C-atoms), 
suggesting that binding of MSAs and TTL does not induce significant structural changes in the 
T2R complex. Both Zampa and EpoA were deeply buried in a pocket formed by predominantly 
hydrophobic residues of helix H7, -strand S7, and the loops H6-H7, S7-H9 (designated the M-
loop (7)) and S9-S10 of -tubulin; this pocket is commonly known as the ‘taxane-pocket’ (8, 9) 
(Fig. 1, B-D).  
 In the T2R-TTL-Zampa complex, the C9 atom of Zampa was covalently bound to the 
NE2 atom of His229 of -tubulin (Fig. S1B), which is consistent with mass spectrometry data 
(10). In addition, two hydrogen bonds were formed between the OH20 group and the O1’ atom 
of Zampa, and the main chain carbonyl oxygen and the NH group of Thr276, respectively. In the 
T2R-TTL-EpoA complex, the O1, OH3, OH7 and N20 groups of EpoA were hydrogen bonded to 
atoms of residues Thr276 (main chain NH), Gln281 (side chain amide nitrogen), Asp226 (side 
chain oxygen) and Thr276 (side chain hydroxyl group) of -tubulin, respectively. The binding 
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mode of EpoA in the tubulin-EpoA structure is fundamentally different from the one proposed 
based on electron crystallography data of zinc-stabilized tubulin sheets (Fig. S2A); however, the 
orientation of the ligand in the taxane-pocket was ambiguous in the electron crystallography 
structure because the density of the ligand in experimental omit maps was discontinuous and 
limited in quality (9, 11). In contrast, the density of EpoA in our tubulin-EpoA X-ray crystal 
structure is very well defined and allowed the orientation of the ligand as well as its 
conformation to be defined unambiguously (Fig. S1C).  
A comparison of the tubulin-Zampa taxane-pocket with the one of tubulin-EpoA showed 
that its conformation is very similar in both complex structures (rmsd of 0.4 Å over 55 C-
atoms), and revealed that the side chains of Zampa and EpoA superimposed well (Fig. S2B). In 
contrast, completely different sets of interactions were established by the two MSAs to anchor 
their macrolide core structures in the taxane-pocket, with the planes of the macrocycles oriented 
at a ~90° angle.  
A hallmark of both the tubulin-Zampa and tubulin-EpoA complex structures was the 
presence of a short helix formed by residues Arg278-Tyr283 in the M-loop of -tubulin (Fig. 2A). 
This segment was largely disordered in the absence of a MSA (Fig. 2B). In contrast, the other 
elements of the taxane-pocket superimposed well between the ligand-bound and -unbound 
states, suggesting that the binding of a MSA is not required to structure these parts of the 
pocket (rmsd of 0.2 Å over 77 C-atoms). The helical conformation of the M-loop induced upon 
ligand binding can be explained by the various hydrophobic and polar contacts established 
between the side chains of Zampa and EpoA, respectively, and residues of the M-loop (Fig. 1, C 
and D). The helix was further stabilized by a characteristic intramolecular hydrogen bonding 
network formed by residues of the M-loop and helix H9 of -tubulin (Fig. 2C).  
The ‘curved’ structure of tubulin in the tubulin-RB3 complex corresponds to the 
conformation of unassembled, free tubulin (12, 13). In contrast, a ‘straight’ conformation of 
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tubulin is found in microtubules (8, 14). To assess possible structural differences between the 
taxane-pocket in unassembled tubulin and microtubules, we compared models of -tubulin in 
the curved (T2R-TTL-Zampa) and straight (14) conformational states. Superimposition of these 
structures showed that the overall architecture of the taxane-pocket is only slightly affected by 
the curved-to-straight structural rearrangements (rmsd of 1.1 Å over 73 C-atoms; Fig. 3A). This 
observation is in agreement with biochemical studies suggesting that some MSAs can bind to 
unassembled and/or oligomeric forms of tubulin (10, 15). The stronger binding of MSAs to 
microtubules can be explained by the disordered nature of the M-loop in unassembled tubulin in 
comparison to its structured state in microtubules (7, 16).  
The M-loop of both - and -tubulin is a crucial element for lateral tubulin contacts 
between protofilaments in microtubules in the absence of ligands (7, 16). To provide structural 
insights into lateral tubulin contacts we modeled the helical conformation of the M-loop in the 
context of the microtubule lattice. For this purpose, we used the straight tubulin structure (14) 
and cryo-electron microscopy reconstructions of microtubules at ~8 Å resolution (7, 16). In 
contrast to the non-native M-loop conformation in zinc-stabilized tubulin sheets (14), the MSA-
stabilized helical M-loop conformation of -tubulin explains well the corresponding density of 
electron microscopy reconstructions of microtubules (Fig. 3B). In our model, Tyr283 of the M-
loop is inserted across protofilaments into a pocket shaped by the S2’-S2’’ -hairpin and the H2-
S3 loop (residues Ala56, Thr57, Val62, Gln85, Arg88, Pro89 and Asp90) of a neighboring -
tubulin subunit (Fig. 3C), secondary structure elements that were not significantly affected by 
the curved-to-straight tubulin conformational transition (Fig. 3A; rmsd of 0.7 Å over 91 C-
atoms). In addition, the M-loop residues Ser280, Gln282, Arg284 and Ala285 were favorably 
positioned to form additional contacts to the neighboring -tubulin. The M-loop of -tubulin in 
our tubulin-MSA complexes was also stabilized in a similar helical conformation, in this case 
due to a crystal contact (Fig. S3). In combination with molecular dynamics simulations (17), 
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these data collectively suggest that the disordered M-loops of both - and -tubulin exhibit an 
intrinsic propensity to form a helix that establishes lateral tubulin contacts in microtubules.  
Our study provides fundamental structural information on the molecular mechanism of 
action of MSAs (Fig. 3D). Apart from additional global effects (17-19), a common feature of 
tubulin activation by MSAs is the formation of a short helix in the M-loop of -tubulin upon MSA 
binding. As M-loop structuring is a crucial prerequisite for lateral tubulin interactions, this effect 
explains how MSAs promote microtubule assembly and stabilization. Our data further suggest 
that the intramolecular interaction network that stabilizes the M-loop helix of both - and -
tubulin also forms in microtubules in the absence of a ligand. We propose that the helical 
structuring of the M-loop facilitates the curved-to-straight conformational change that occurs 
upon incorporation of tubulin into microtubules. In this context, the binding of a MSA leads to 
tubulin pre-organization according to the gross structural requirements of the assembly process, 
thus reducing the entropy loss associated with microtubule formation. Our model implies in turn 
that dissolution of the helical structure of the M-loops is an early molecular event in the process 
of microtubule disassembly.  
The high-resolution structural information obtained for the tubulin-MSA complexes 
reported here opens the possibility for structure-guided drug engineering. While the structure-
activity relationship of epothilones has been explored extensively (20) and one epothilone 
derivative, ixabepilone, has been approved by the FDA for breast cancer treatment (21), little 
structure-activity work has been reported on Zampa (22). Zampa exhibits favorable properties 
that could make it an attractive lead compound (10). It is a very potent MSA that exerts its action 
through covalent binding to tubulin, which might provide superior activity in the case of P-
glycoprotein-mediated multidrug resistance.  
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Figure Legends 
 
Fig. 1. Tubulin-Zampa and tubulin-EpoA complex structures. (A) Chemical structure of (-)-
Zampa and EpoA. (B) Overall view of the complex formed between tubulin (gray surface; M-
loop in yellow) and Zampa (green spheres). The dashed box depicts the area shown in more 
details in panel (C). (C) and (D) Close up views of the interaction network observed between 
Zampa (green sticks; panel C) or EpoA (light green sticks; panel D) and -tubulin (gray cartoon). 
Interacting residues of -tubulin are shown in stick representation. Oxygen and nitrogen atoms 
are colored in red and blue, respectively, carbon atoms in green (Zampa and EpoA) or gray and 
yellow (-tubulin). Hydrogen bonds are depicted as black dashed lines. The covalent bond 
between the C9 atom of Zampa and the NE2 atom of His229 is indicated by an orange stick.  
 
Fig. 2. Conformation of the M-loop of -tubulin. (A) and (B) 2mFo-DFc (grey mesh, contoured at 
1.0) and mFo-DFc (green and red mesh, +/- 3.0) electron density maps of the region 
surrounding the M-loop of -tubulin in the T2R-TTL-Zampa (A) and T2R-TTL (B) complexes. (C) 
Close up view of the Zampa-induced intramolecular interaction network that contributes to the 
stabilization of the M-loop helix.  
 
Fig. 3. Lateral tubulin interactions in microtubules. (A) Superimposition of the taxane-pocket 
(right) and M-loop-contacting elements across protofilaments (left) in curved (T2R-TTL-Zampa; 
gray) and straight (PDP ID 1JFF; light blue) -tubulin. (B) 8.2 Å cryo-electron microscopy map 
of a microtubule viewed from its luminal side (gray surface; EMDB-map 1788). Two chimeric 
molecules composed of straight -tubulin (cartoon representation) and elements shaping the 
taxane-pocket in the curved tubulin-Zampa complex (A) are fitted in the map. (C) Close up view 
of the lateral -tubulin contact model shown in panel (B). (D) Proposed molecular mechanism of 
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action of MSAs on tubulin and microtubules. (1) Binding of a MSA (rhomboid) to the taxane-site 
structures the disordered M-loop of -tubulin (dashed line) into a helix (cylinder). (2) The MSA-
stabilized M-loop promotes tubulin polymerization. (3) The M-loop helices of - and -tubulin are 
also formed in the context of the microtubule in the absence of a ligand. (4) All taxane-site 
MSAs bind to tubulin in the microtubule to stabilize lateral contacts. For more details, see text.  
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Materials and Methods 
Protein and MSA preparation 
The gene encoding the chicken TTL orthologue was initially cloned from chicken 
whole brain cDNA (BioChain), and then transferred into the negative selection vector 
NSKn1 (23) with a C-terminal hexahistidine tag. Recombinant TTL was overexpressed in 
the E. coli strain BL21 (DE3). Cells were grown at 37°C in LB medium supplemented 
with 50 mg/l kanamycin to reach an OD600 of 1.2. After induction with 1 mM IPTG the 
cultures were shaken at 20°C for 20 h. Cells were harvested by centrifugation, 
resuspended in lysis buffer (50 mM Tris pH 7.5, 1 M NaCl, 10% glycerol, 2.5 mM 
MgCl2) supplemented with 10 mM -ME, protease inhibitors (1 tablet complete (Roche) 
/ 50 ml buffer) and DNAse, and disrupted using an Emulsiflex homogenizer. The lysate 
was clarified by centrifugation at 100,000 g for 45 min and loaded onto a 5 ml HisTrap 
affinity column (GE Healthcare), washed with 20 mM imidazole and eluted with a 
gradient from 20 to 250 mM imidazole in 20 column volumes. The fractions containing 
TTL protein were pooled, concentrated to 5 ml using a Centriprep (Amicon; Mw cutoff 
30,000) and loaded onto a Superdex 200 16/60 column for the final purification step in 
20 mM Bis Tris Propane, pH 6.5 supplemented with 200 mM NaCl, 2.5 mM MgCl2, 
5 mM -mercaptoethanol and 1% glycerol. The protein containing fractions were 
collected, concentrated to ~20 mg/ml and frozen in aliquots in liquid nitrogen for storage. 
 Bovine brain tubulin was prepared according to well established protocols (24). 
The stathmin-like domain clone of RB3 was a kind gift by A. Sobel. The protein was 
prepared according to (6). The total synthesis of (-)-zampanolide (Zampa) has been 
reported (22). Epothilone A (EpoA) was a kind gift of Novartis Pharma.  
 
Crystallization, data collection and structure solution 
The Zampa adduct (TZ) was prepared by a 1 hour incubation of tubulin (3 mg/ml) at 
4°C in the presence of a slight molar excess of the compound. The T2R-TTL-Zampa 
complex was formed by mixing the individual components at a ratio of 2:1.3:1.2 
(TZ:RB3:TTL) supplemented with 1 mM AMPPCP, 5 mM tyrosinol and 10 mM DTT, 
and concentrated to 20 mg/ml prior to crystallization. The T2R-TTL-EpoA complex was 
prepared by mixing 20 mg/ml T2R-TTL with 0.5 mM EpoA, 1 mM AMPPCP, 5 mM 
tyrosine and 10 mM DTT. The T2R-TTL complex without MSA was prepared by mixing 
20 mg/ml T2R-TTL with 1 mM AMPPCP, 5 mM tyrosinol and 10 mM DTT.  
T2R-TTL and T2R-TTL-MSA complexes were crystallized by the sitting-drop 
vapor-diffusion method at 20°C. Crystals grew over night in precipitant solution 
consisting of 3% PEG 4K, 4-6% glycerol, 30 mM MgCl2, 30 mM CaCl2, 100 mM 
MES/Imidazole pH 6.7 and reached their maximum dimensions within one week. They 
belonged to space group P212121, with one T2R-TTL-MSA complex in the asymmetric 
unit. Native data were collected at 100K at beamlines X06SA and X06DA of the Swiss 
Light Source (SLS, Villigen PSI). Data were processed and merged with XDS (25). The 
structure was determined by molecular replacement with PHASER (26) using the 
individual components of the complex as search models (PDB IDs 3RYC and 3TIN). The 
initial molecular replacement model was first fitted by rigid body refinement followed by 
simulated annealing and restrained refinement in Phenix (27) with riding hydrogens. The 
resulting model was further improved through iterative model rebuilding in Coot (28) and 
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refinement in Phenix. NCS restraints were applied in initial refinement stages and then 
omitted in the final cycles of refinement to account for structural variations between the 
ncs-related copies of - and -tubulin. TLS-refinement was included in the final cycles 
of refinement. The quality of the structure was assessed with MolProbity (29). Data 
collection and refinement statistics are given in Table S1. 
 
Structural analysis and figure preparation 
Figures were prepared using PyMOL (The PyMOL Molecular Graphics System, 
Version 1.4.1. Schrödinger, LLC). Chains in the T2R-TTL complex were defined as 
follows: chain A, 1-tubulin; chain B, 1-tubulin; chain C, 2-tubulin; chain D, 2-
tubulin; chain E, RB3; chain F, TTL. See also Fig. S1A.  
Chains C and D were used throughout for the structural analyses and figure 
preparation. The M-loop and MSA in chain B is less well defined. We thus decided not to 
model these elements in chain B. In contrast, the electron density of the M-loop and MSA 
in chain D allowed for a full modeling of this site in the 2-tubulin molecule (Fig. 2A).  
Structural comparison and modeling of the ‘curved’ and ‘straight’ (PDB ID 1JFF) 
tubulin structures (Fig. 3) was performed by superimposing the N-terminal nucleotide-
binding and C-terminal domains of -tubulin (6).  
The tubulin-TTL interaction is described in details in (31).  
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Fig. S1. Overall structure of the T2R-TTL-MSA complex and covalent binding of 
Zampa to His229 of -tubulin.  
(A) Overall structure of the 2:1:1:1 tubulin-RB3-TTL-MSA complex. Tubulin 
(gray), TTL (raspberry) and RB3 (blue) are shown in cartoon representations; the MSA 
(Zampa) is depicted in green spheres representation. (B) Simulated annealing omit maps 
of the Zampa binding site showing the covalent link to His229 of -tubulin. The SigmaA-
weighted 2mFo-DFc (grey mesh) and mFo-DFc (green mesh) electron density maps are 
contoured at 1.0 and +/- 3.0, respectively. The Zampa molecule (green) and His229 
(cyan) are in stick representation. (C) Simulated annealing omit maps of the Zampa (left 
panel) and EpoA (right panel) binding sites. The SigmaA-weighted 2mFo-DFc (grey 
mesh) and mFo-DFc (green mesh) electron density maps are contoured at 1.0 and +/- 
3.0, respectively. The Zampa and EpoA molecules are shown in dark and light green 
stick representation, respectively. 
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Fig. S2. Comparison of EpoA and Zampa in different complex structures with 
tubulin.  
(A) The structure of EpoA bound in the taxane-pocket of ‘straight’ tubulin (obtained 
from zinc sheets (cyan; PDB ID 1TVK)) is superimposed onto the one observed in 
‘curved’ tubulin (light green; T2R-TTL-EpoA). (B) Close up views of the 
superimposition of the tubulin-Zampa (gray) and tubulin-EpoA (magenta) complex 
structures. The Zampa and EpoA molecules are shown in dark and light green stick 
representation, respectively.  
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Fig. S3. Conformation of the M-loop of -tubulin in T2R-TTL-MSA. 
(A) The M-loop of -tubulin is stabilized in a helical conformation by a crystal contact 
shown in (B) and by an intermolecular hydrogen-bonding network (black dashed lines). 
Secondary structure elements are shown in cartoon representation; residue side chains are 
shown in stick representation. -strand S7, the M-loop and helix H9 are colored in 
orange; the S9-S10 loop and -strand S10 in gray (only depicted in panel (A)). In panel 
(B), RB3 (blue), - and -tubulin (dark and light gray, respectively) of a neighboring 
T2R-TTL-MSA complex in the crystal are depicted.  
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Table S1. Data collection and refinement statistics. 
aHighest shell statistics are in parentheses. bAs defined by Karplus & Diederichs (30). cAs 
defined by MolProbity (29). 
 
Data collectiona T2R-TTL-Zampa T2R-TTL-EpoA T2R-TTL 
Space group P212121 P212121 P212121 
Cell dimensions    
     a, b, c (Å) 104.8, 158.6, 179.2 103.6, 155.1, 180.4 104.2, 156.5, 181.5 
Resolution (Å) 79.4 – 1.80 (1.85 – 1.80) 77.6 – 2.3 (2.36 -2.30) 71.8 - 2.2 (2.26 – 2.20) 
Rmeas (%) 10.7 (256.5) 13.6 (248.5) 9.7 (130.9) 
Rpim (%) 3.1 (74.6) 4.0 (71.5) 3.3 (98.0) 
CChalfb 99.9 (53.7) 99.9 (47.7) 99.9 (64.7) 
<I>/<σI> 13.4 (1.0) 13.8 (1.2) 16.2 (2.2) 
Completeness (%) 99.8 (99.0) 100 (100) 99.2 (93.9) 
Redundancy 13.5 (13.1) 13.6 (13.8) 13.2 (11.9) 
    
Refinement    
Resolution (Å) 79.4 – 1.80 77.6 – 2.3 71.8 – 2.2 
No. unique reflections 274515 (13945 in test set) 129379 (6505 in test set) 149390 (7514 in test set) 
Rwork/Rfree (%) 17.2 / 20.5 19.0 / 24.6 16.8 / 20.8 
Average B-factors (Å2)    
     complex 44.1 66.0 55.7 
     solvent 48.1 51.2 50.4 
     MSA (chain D) 40.0 64.7  - 
R.m.s. deviation from ideality    
     Bond length (Å) 0.008 0.005 0.008 
     Bond angles (°) 1.100 0.943 1.111 
Ramachandran statisticsc    
     Favored regions (%) 98.3 97.4 97.8 
     Allowed regions (%) 1.6 2.5 2.1 
     Outliers (%) 0.1 0.1 0.1 
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